These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 3978312)

  • 21. Differential inhibition of 5-hydroxytryptamine (5-HT) mediated contraction of rat thoracic aortae by phentolamine and tolazoline: correlation with inhibition of 5-HT binding and calcium ion.
    Curro FA; Greenberg S
    Methods Find Exp Clin Pharmacol; 1983; 5(2):107-20. PubMed ID: 6876942
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evidence for two types of excitatory receptor for 5-hydroxytryptamine in dog isolated vasculature.
    Apperley E; Feniuk W; Humphrey PP; Levy GP
    Br J Pharmacol; 1980 Feb; 68(2):215-24. PubMed ID: 7357206
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Tryptamine-induced vasoconstrictor responses in rat caudal arteries are mediated predominantly via 5-hydroxytryptamine receptors.
    Bradley PB; Humphrey PP; Williams RH
    Br J Pharmacol; 1985 Apr; 84(4):919-25. PubMed ID: 3159458
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A pre-junctional action of 5-hydroxytryptamine and methysergide on noradrenergic nerves in dog isolated saphenous vein.
    Watts AD; Feniuk W; Humphrey PP
    J Pharm Pharmacol; 1981 Aug; 33(8):515-20. PubMed ID: 6115926
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Structure-activity study of some newly synthesized ergoline derivatives on 5-HT2 receptors and alpha-adrenoceptors in rabbit isolated aorta.
    Krisch I; Budihna MV; Rucman R
    Pharmacology; 1992; 45(4):195-208. PubMed ID: 1332086
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Receptor mechanisms for 5-hydroxytryptamine in rabbit arteries.
    Black JL; French RJ; Mylecharane EJ
    Br J Pharmacol; 1981 Nov; 74(3):619-26. PubMed ID: 6271321
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hypoxia and response of human umbilical artery strips to 5-hydroxytryptamine: role of prostaglandin F2 alpha.
    De Moraes S; Carvalho JC; Cavalcante MT; Mathias RS
    Gen Pharmacol; 1997 Jan; 28(1):77-83. PubMed ID: 9112081
    [TBL] [Abstract][Full Text] [Related]  

  • 28. 5-HT1-like receptors mediate 5-hydroxytryptamine-induced contraction of human isolated basilar artery.
    Parsons AA; Whalley ET; Feniuk W; Connor HE; Humphrey PP
    Br J Pharmacol; 1989 Feb; 96(2):434-40. PubMed ID: 2538194
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparative effects of noradrenaline and serotonin in a central and a peripheral artery in vitro.
    Tayo FM
    Afr J Med Med Sci; 1983; 12(3-4):139-43. PubMed ID: 6326547
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evidence for the existence of 5-hydroxytryptamine receptors, which are not of the 5-HT2 type, mediating contraction of rabbit isolated basilar artery.
    Bradley PB; Humphrey PP; Williams RH
    Br J Pharmacol; 1986 Jan; 87(1):3-4. PubMed ID: 3955301
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Blockade by phentolamine of the potentiation of histamine-induced vasoconstriction caused by serotonin and methysergide in the rabbit ear artery.
    Carroll PR; Morgans D; Glover WE
    Clin Exp Pharmacol Physiol; 1977; 4(1):43-8. PubMed ID: 884902
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The subtype of serotonin (5-HT) receptors in the rat pulmonary artery.
    Uma S; Tuncer M; Kayaalp SO
    Arch Int Pharmacodyn Ther; 1987 Aug; 288(2):248-55. PubMed ID: 3675084
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Serotonin antagonism in isolated canine cerebral arteries.
    Toda N; Hayashi S; Fu WL; Nagasaka Y
    Jpn J Pharmacol; 1976 Feb; (1):57-63. PubMed ID: 1263357
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pharmacological analysis of 5-hydroxytryptamine receptors in isolated intracranial and extracranial vessels of cat and man.
    Edvinsson L; Hardebo JE; Owman C
    Circ Res; 1978 Jan; 42(1):143-51. PubMed ID: 618595
    [No Abstract]   [Full Text] [Related]  

  • 35. Influence of calcium entry blockers and calmodulin inhibitors on 5-hydroxytryptamine-, potassium- and calcium-induced contractions in human umbilical artery in-vitro.
    Medeiros YS; Calixto JB
    J Pharm Pharmacol; 1991 Jun; 43(6):411-6. PubMed ID: 1681054
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Differential classification of vascular smooth muscle and endothelial cell 5-HT receptors by use of tryptamine analogues.
    Leff P; Martin GR; Morse JM
    Br J Pharmacol; 1987 Jun; 91(2):321-31. PubMed ID: 3607360
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison of vasorelaxants in human basilar arteries and umbilical arteries.
    White RP
    Eur J Pharmacol; 1988 Oct; 155(1-2):109-15. PubMed ID: 3243328
    [TBL] [Abstract][Full Text] [Related]  

  • 38. 5-Hydroxytryptamine-induced contraction of human isolated umbilical artery and its dependence on cellular and extracellular Ca++.
    Doğan N; Ciçek E; Cenik AG; Singirik E; Kiliç M; Ozcan AS
    Arch Int Pharmacodyn Ther; 1991; 312():79-85. PubMed ID: 1772342
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pharmacological properties of the receptor(s) involved in the 5-hydroxytryptamine-induced contraction of the feline middle cerebral artery.
    Hamel E; Robert JP; Young AR; MacKenzie ET
    J Pharmacol Exp Ther; 1989 Jun; 249(3):879-89. PubMed ID: 2732950
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Contribution of cellular and extracellular Ca2+ during 5-hydroxytryptamine-induced contractions of rabbit ear artery.
    Maggi CA; Manzini S; Meli A
    Eur J Pharmacol; 1983 Oct; 94(3-4):251-60. PubMed ID: 6418554
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.